1,457 results on '"Masliah, E"'
Search Results
152. Molecular mechanisms of neurodegeneration in Alzheimer's disease
153. An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease
154. Beclin 1 Gene Transfer Activates Autophagy and Ameliorates the Neurodegenerative Pathology in -Synuclein Models of Parkinson's and Lewy Body Diseases
155. S9.3 Autonomic dysfunction in mice overexpressing human wildtype alpha synuclein
156. Loss of Hsp70 Exacerbates Pathogenesis But Not Levels of Fibrillar Aggregates in a Mouse Model of Huntington's Disease
157. Deletion of the 7 Nicotinic Acetylcholine Receptor Gene Improves Cognitive Deficits and Synaptic Pathology in a Mouse Model of Alzheimer's Disease
158. Molecular mechanism of pore creation in bacterial membranes by amyloid proteins
159. Regulation of Synaptic Structure by Ubiquitin C-Terminal Hydrolase L1
160. Alterations in corticostriatal synaptic plasticity in mice overexpressing human α-synuclein
161. Defective insulin signaling pathway and increased glycogen synthase kinase-3 activity in the brain of diabetic mice: Parallels with Alzheimer's disease and correction by insulin
162. Simulation and modeling of synuclein-based ‘protofibril' structures: as a means of understanding the molecular basis of Parkinson's disease
163. Activation of the Amyloid Cascade in Apolipoprotein E4 Transgenic Mice Induces Lysosomal Activation and Neurodegeneration Resulting in Marked Cognitive Deficits
164. Casein kinase II alteration precedes tau accumulation in tangle formation
165. Human Immunodeficiency Virus-1/Surface Glycoprotein 120 Induces Apoptosis through RNA-Activated Protein Kinase Signaling in Neurons
166. Transgenic animal models of neurodegenerative diseases and their application to treatment development☆
167. Escalating dose-multiple binge methamphetamine exposure results in degeneration of the neocortex and limbic system in the rat
168. DLB and PDD boundary issues
169. Cardiac death in a patient with adult-onset Still's disease treated with the interleukin 1 receptor inhibitor anakinra
170. Neuroprotective Effects of Regulators of the Glycogen Synthase Kinase-3 Signaling Pathway in a Transgenic Model of Alzheimer's Disease Are Associated with Reduced Amyloid Precursor Protein Phosphorylation
171. Adult neurogenesis in Parkinson's disease
172. Behavioral and histopathological consequences of paraquat intoxication in mice: Effects of α-synuclein over-expression
173. Behavioral effects of dopaminergic agonists in transgenic mice overexpressing human wildtype α-synuclein
174. Changing Patterns in the Neuropathogenesis of HIV During the HAART Era
175. Reduzierte adulte Neurogenese: Potentieller Mechanismus für gestörte Riechfunktion bei M. Parkinson
176. Humanes Wild-typ alpha-Synuclein vermindert die adulte Neurogenese
177. Humanes Wildtyp alpha-Synuklein vermindert die adulte Neurogenese
178. A vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease
179. Reduced expression of the Sp4 gene in mice causes deficits in sensorimotor gating and memory associated with hippocampal vacuolization
180. Amelioration of the cerebrovascular amyloidosis in a transgenic model of Alzheimer?s disease with the neurotrophic compound Cerebrolysin?
181. 85 THE ROLE OF AMYLOID IN THE CELLULAR PATHOLOGY OF ALZHEIMER'S DISEASE.
182. THE ROLE OF AMYLOID IN THE CELLULAR PATHOLOGY OF ALZHEIMERʼS DISEASE.
183. 66 THE ROLE OF AMYLOID IN THE CELLULAR PATHOLOGY OF ALZHEIMER'S DISEASE.
184. Aβ1–42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD
185. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis
186. Analysis of Result Variability from High-Density Oligonucleotide Arrays Comparing Same-Species and Cross-Species Hybridizations
187. Absence of elevated anti- -synuclein and anti-EBV latent membrane protein antibodies in PD
188. The National NeuroAIDS Tissue Consortium:a new paradigm in brain banking with an emphasis on infectious disease
189. Altered expression of synaptic proteins occurs early during progression of Alzheimer’s disease
190. The Role of Amyloid in the Cellular Pathology of Alzheimer's Disease
191. The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease
192. Neuronal Death and Perinatal Lethality in Voltage-Gated Sodium Channel αII-Deficient Mice
193. Alzheimer's Disease-like Cerebrovascular Pathology in Transforming Growth Factor-beta1 Transgenic Mice and Functional Metabolic Correlates
194. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer’s disease
195. Cholinergic dysfunction in diseases with Lewy bodies
196. Alternative splicing patterns of CYP2D genes in human brain and neurodegenerative disorders
197. Synaptic alterations in apolipoprotein E knockout mice
198. Association of CYP2D microsatellite polymorphism with Lewy body variant of Alzheimer's disease
199. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), and apolipoprotein E receptor, with late-onset Alzheimer's disease
200. Neurocognitive disturbances in HIV, including HIV-assoclated dementia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.